Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II study of KN-046 in patients with thymic carcinoma begins

Dec. 15, 2020

Enrollment ongoing in first-in-human study of JNJ-74856665 in AML or MDS

Dec. 15, 2020

PMD-026 shows safety and initial signs of activity in metastatic breast cancer

Dec. 14, 2020

Phase III study of ruxolitinib in COVID-19 does not meet primary endpoint

Dec. 14, 2020

Ultimovacs reports 5-year survival data from phase I trial of UV-1 in metastatic melanoma

Dec. 14, 2020

Akari releases long-term data on nomacopan in paroxysmal nocturnal hemoglobinuria

Dec. 14, 2020

Aerpio announces phase II data on razuprotafib in glaucoma

Dec. 14, 2020

Amarin reports data on Vascepa in COVID-19 outpatients

Dec. 14, 2020

MET no better than EMT for cancer metastases

Dec. 14, 2020

Suzhou Ribo Life Science patents FXI-targeting siRNA

Dec. 14, 2020

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...